Differentially expressed genes in orbital adipose/connective tissue of thyroid-associated orbitopathy

被引:1
|
作者
Wang, Yan [1 ]
Liu, Yanqiu [1 ]
Cai, Jiping [1 ]
Zong, Tianyi [1 ]
Zhang, Ziyin [1 ]
Xie, Tianhua [1 ]
Mu, Tong [1 ]
Wu, Meili [2 ]
Yang, Qian [1 ,2 ]
Wang, Yangningzhi [1 ]
Wang, Xiaolu [2 ]
Yao, Yong [1 ]
机构
[1] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Ophthalmol, Wuxi, Peoples R China
[2] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Ctr Clin Res, Wuxi, Peoples R China
来源
PEERJ | 2023年 / 11卷
基金
中国国家自然科学基金;
关键词
mology Thyroid Associated Ophthalmopathy; High-throughput sequencing; Differentially expressed genes; mRNA; Inflammation; GRAVES ORBITOPATHY; OPHTHALMOPATHY; PATHOGENESIS; DISEASE; FIBROBLASTS; INVOLVEMENT; MECHANISMS; RECEPTOR;
D O I
10.7717/peerj.16569
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Thyroid-associated orbitopathy (TAO) is a disease associated with autoimmune thyroid disorders and it can lead to proptosis, diplopia, and vision threatening compressive optic neuropathy. To comprehensively understand the molecular mechanisms underlying orbital adipogenesis in TAO, we characterize the intrinsic molecular properties of orbital adipose/connective tissue from patients with TAO and control individuals.Methods. RNA sequencing analysis (RNA-seq) was performed to measure the gene expression of orbital adipose/connective tissues of TAO patients. Differentially expressed genes (DEGs) were detected and analyzed through Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, and Gene Set Enrichment Analysis (GSEA). The protein-protein interaction (PPI) network was constructed using the STRING database, and hub genes were identified by the Cytoscape plug-in, cytoHubba. We validated several top DEGs through quantitative real-time polymerase chain reaction (qRT-PCR).Results. We identified 183 DEGs in adipose tissue between TAO patients (n = 3) and control patients (n = 3) through RNA sequencing, including 114 upregulated genes and 69 downregulated genes. The PPI network of these DEGs had 202 nodes and 743 edges. PCR-based validation results of orbital adipose tissue showed multiple top-ranked genes in TAO patients (n = 4) are immune and inflammatory response genes compared with the control individual (n = 4). They include ceruloplasmin isoform x3 (CP), alkaline tissue-nonspecific isozyme isoform x1 (ALPL), and angiotensinogen (AGT), which were overrepresented by 2.27-to 6.40-fold. Meanwhile, protein mab-21-like 1 (MAB21L1), phosphoinositide 3-kinase gamma-subunit (PIK3C2G), and clavesin-2 (CLVS2) decreased by 2.6% to 32.8%. R-spondin 1 (RSPO1), which is related to oogonia differentiation and developmental angiogenesis, was significantly downregulated in the orbital muscle tissues of patients with TAO compared with the control groups (P = 0.024).Conclusions. Our results suggest that there are genetic differences in orbital adipose connective tissues derived from TAO patients. The upregulation of the inflammatory response in orbital fat of TAO may be consistent with the clinical phenotype like eyelid edema, exophthalmos, and excess tearing. Downregulation of MAB21L1, PIK3C2G,
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Choroidal thickness in thyroid-associated orbitopathy
    Lai, Frank H. P.
    Iao, Tiara W. U.
    Ng, Danny S. C.
    Young, Alvin L.
    Leung, Joy
    Au, Alvin
    Ko, Simon T. C.
    Chong, Kelvin K. L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 (07): : 918 - 924
  • [32] Ophthalmic management of thyroid-associated orbitopathy
    Guthoff, R
    Schittkowski, M
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S175 - S176
  • [33] Glabellar rhytids in thyroid-associated orbitopathy
    Saks, ND
    Burnstine, MA
    Putterman, AM
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 17 (02): : 91 - 95
  • [34] Identification and verification of the optimal feature genes of ferroptosis in thyroid-associated orbitopathy
    Li, Xuemei
    Xiong, Chao
    Wang, Siyi
    Ren, Zhangjun
    Jin, Qi
    Yu, Jinhai
    Chen, Yunxiu
    Gan, Puying
    Xu, Qihua
    Wang, Yaohua
    Liao, Hongfei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Medical treatment of thyroid-associated orbitopathy
    Prummel, MF
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S198 - S200
  • [36] Animal model of thyroid-associated orbitopathy
    Ludgate, M
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S158 - S159
  • [37] Tocilizumab for the Management of Thyroid-Associated Orbitopathy
    Smith, Loreley D.
    Moscato, Eve E.
    Seiff, Stuart R.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (02): : 188 - 192
  • [38] Evaluation of the association between subconjunctival orbital fat prolapse and thyroid-associated orbitopathy
    Han, Sang Beom
    CLINICAL INTERVENTIONS IN AGING, 2017, 12 : 531 - 532
  • [39] Neuroradiological diagnosis in thyroid-associated orbitopathy
    Müller-Forell, W
    Pitz, S
    Mann, W
    Kahaly, GJ
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S177 - S183
  • [40] Risk of smoking in thyroid-associated orbitopathy
    Mann, K
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 : S164 - S167